An internal standard for the quantification of cycloguanil
Related Products
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Cycloguanil-d6 (hydrochloride)

Item No. 31496

Technical Information
Formal Name
1-(4-chlorophenyl)-1,6-dihydro-6,6-dimethyl-d3-1,3,5-triazine-2,4-diamine, monohydrochloride
CAS Number
2712364-69-5
Synonyms
  • Chloroguanide Triazine-d6
Molecular Formula
C11H8ClD6N5 • HCl
Formula Weight
Purity
≥99% deuterated forms (d1-d6)
A solid
SMILES
ClC1=CC=C(N2C(N)=NC(N)=NC2(C([2H])([2H])[2H])C([2H])([2H])[2H])C=C1.Cl
InChi Code
InChI=1S/C11H14ClN5.ClH/c1-11(2)16-9(13)15-10(14)17(11)8-5-3-7(12)4-6-8;/h3-6H,1-2H3,(H4,13,14,15,16);1H/i1D3,2D3;
InChi Key
MOUAPRKJJUXEIE-TXHXQZCNSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    Cycloguanil-d6 is intended for use as an internal standard for the quantification of cycloguanil (Item No. 16861) by GC- or LC-MS. Cycloguanil is the active metabolite of the antimalarial prodrug proguanil.1 Cycloguanil is formed from proguanil by the cytochrome P450 (CYP) isoforms CYP2C19 and CYP3A in human liver microsomes. It is an inhibitor of dihydrofolate reductase (DHFR; Kis = 1.5 and 0.79 nM for the P. falciparum and P. berghei enzymes, respectively).2,3 It is active against ten P. falciparum field isolates (IC50s = 0.12-1,400 µg/ml).2 Cycloguanil reduces parasitemia in a mouse model of P. berghei infection (ED50 = 2 mg/kg).4 It also reduces parasitemia in a rhesus monkey model of P. cynomolgi infection when administered at a dose of 0.3 mg/kg.5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Birkett, D.J., Rees, D., Anderson, T., et alIn vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase. Br. J. Clin. Pharmacol. 37(5), 413-420 (1994).

    2. Foote, S.J., Galatis, D., and Cowman, A.F. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc. Natl. Acad. Sci. USA 87(8), 3014-3017 (1990).

    3. Yuthavong, Y., Vilaivan, T., Chareonsethakul, N., et alDevelopment of a lead inhibitor for the A16V+S108T mutant of dihydrofolate reductase from the cycloguanil-resistant strain (T9/94) of Plasmodium falciparum. J. Med. Chem. 43(14), 2738-2744 (2000).

    4. Knight, D.J., and Peters, W. The antimalarial activity of N-benzyloxydihydrotriazines. I. The activity of clociguanil (BRL 50216) against rodent malaria, and studies on its mode of action. Ann. Trop. Med. Parasitol. 74(4), 393-404 (1980).

    5. Schmidt, L.H., Loo, T.L., Fradkin, R., et alAntimalarial activities of triazine metabolites of chlorguanide and dichlorguanide. Proc. Soc. Exp. Biol. Med. 80(2), 367-370 (1952).